Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization

Related

• 

  2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Expert Panel: PVR

  Christina Y Weng, MD, MBA, FASRS

  Lejla Vajzovic, MD, FASRS

  Isabela Martins Melo, MD

  Sarah Syeda, MD

  Prashant Keshao Bawankule, M.S.

  Leo A. Kim, MD, PhD

  Annual Meeting Talks

  2024

• 

  Effect of Adjuvant Topical Dorzolamide-Timolol Versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

  Jason Hsu, MD

  On Demand Cases, Courses, and Papers

  2020